Journal Article Summary
The article investigates the safety and effectiveness of avanafil, a medication used to treat erectile dysfunction (ED), specifically in Korean men. ED is a common condition that can significantly impact quality of life and relationships. While various treatments exist, avanafil is noted for its rapid onset and high selectivity for the enzyme it targets, which may offer advantages over older medications. This study aims to provide more clinical data on avanafil, especially since most previous research has focused on higher doses, leaving a gap in knowledge about lower doses.
In this study, 158 participants were randomly assigned to receive either avanafil at doses of 50, 100, or 200 mg, or a placebo, for eight weeks. The primary measure of effectiveness was the erectile function score from the International Index of Erectile Function (IIEF) questionnaire. Results showed that participants taking avanafil, particularly at the 100 mg and 200 mg doses, experienced significant improvements in erectile function compared to those on placebo. Additionally, most side effects reported were mild and resolved without intervention, indicating that avanafil is generally well-tolerated.
However, the study has limitations that should be considered. It focused solely on Korean patients, which may affect the generalizability of the findings to other populations. The treatment duration was relatively short at eight weeks, and longer-term effects remain unclear. Patients should discuss these findings with their healthcare providers, especially regarding the appropriate dosage and potential side effects of avanafil, to ensure safe and effective treatment for erectile dysfunction.
Medical Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Park Hyun Jun, Kim Sae Woong, Kim Je Jong, Lee Sung Won, Paick Jae Seung, Ahn Tae Young, Park Kwangsung, Park Jong Kwan, et al.. A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Therapeutic Confirmatory Study to Evaluate the Safety and Efficacy of Avanafil in Korean Patients with Erectile Dysfunction. Journal of Korean Medical Science 2017. DOI: 10.3346/jkms.2017.32.6.1016. PMID: 28480661. PMCID: PMC5426242.
Featured Pill Pals Product
Sildenafil 25 mg Tablets --- 4 Count --- --- Torrent Pharma --- Generic for Viagra --- Total Dose = 1 Pill / Week --- 28 Day's Supply
Sildenafil 25 mg Tablets — 4 Count — — Torrent Pharma — Generic for Viagra — Total Dose = 1 Pill / Week — 28 Day’s Supply is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
